TFAP2A

TFAP2A

Target · Transcription factor

TFAP2A Transcription factor AP-2 alpha · activating enhancer-binding protein 2 alpha

TFAP2A (transcription factor AP-2 alpha, also known as AP-2, AP-2alpha, TFAP2 and AP2TF) is a sequence-specific DNA-binding transcription factor of the AP-2 family. It regulates selected genes through inducible viral and cellular enhancer elements and contributes to several developmental programmes. Browse Assay Genie's current range of TFAP2A research reagents below, or read on for the biology behind the target.

Nuclear proteinSequence-specific DNA bindingLinked to BOFS
437 aa
Protein length
~48 kDa
Molecular weight
6p24.3
Gene locus
AP-2 family
Protein family
Target information

What is TFAP2A (transcription factor AP-2 alpha)?

TFAP2A binds the consensus sequence 5'-GCCNNNGGC-3' and interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. It acts as either a homodimer or a heterodimer with related family members, and it can activate some genes while suppressing others. Reported targets of repression include MCAM/MUC18 and C/EBP alpha. The protein is also a transcriptional repressor of MYC and is involved in the negative regulation of canonical Wnt signalling.

AP-2 factors activate genes involved in a broad range of biological functions, including proper development of the eye, face, body wall, limb and neural tube. Within the family, AP-2-alpha is the only member required for early morphogenesis of the lens vesicle. Together with the coactivator CITED2, it stimulates transcription from the PITX2 P1 promoter, and it associates with chromatin at the PITX2 P1 promoter region. The TFAP2A protein is localised to the nucleus, consistent with its role in transcriptional control.

The human TFAP2A gene produces three transcript variants that encode different isoforms. Defects in the gene are a cause of branchiooculofacial syndrome (BOFS). The HGNC name reflects the earlier description of the protein as activating enhancer-binding protein 2 alpha. Related family members include TFAP2B and TFAP2C, and mouse and rat each carry a Tfap2a ortholog.

Developmental biology

TFAP2A is linked to development of the eye, face, body wall, limb and neural tube, and is needed for early lens vesicle morphogenesis.

Transcriptional regulation

It binds 5'-GCCNNNGGC-3' to activate some genes and repress others, including MCAM/MUC18 and C/EBP alpha.

Wnt and MYC signalling

TFAP2A is involved in negative regulation of canonical Wnt signalling and acts as a transcriptional repressor of MYC.

Craniofacial disease genetics

Defects in the TFAP2A gene cause branchiooculofacial syndrome (BOFS), making it relevant to studies of syndromic developmental disorders.

Background

TFAP2A frequently asked questions

What does TFAP2A do?

TFAP2A is a sequence-specific DNA-binding transcription factor that binds 5'-GCCNNNGGC-3'. It regulates selected genes by activating some and suppressing others, and it supports development of the eye, face, body wall, limb and neural tube. It works as a homodimer or as a heterodimer with similar family members.

What other names and isoforms does TFAP2A have?

TFAP2A is also called AP-2, AP-2alpha, TFAP2 and AP2TF. Its earlier name was activating enhancer-binding protein 2 alpha. RefSeq reports three transcript variants for the human gene, and these encode different isoforms of the protein.

Is TFAP2A conserved and linked to disease?

Mouse and rat both have a Tfap2a ortholog. In humans, defects in the TFAP2A gene are a cause of branchiooculofacial syndrome (BOFS). Check the datasheet of any product for its validated reactivity before using it with a given species.

Explore

Related targets

Other AP-2 family transcription factors with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P05549; product specifications from Assay Genie datasheets.

TFAP2A Product listing